NUCLEIX
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Jul 2019)
What this means for you
This application is over — abandoned 15 Jul 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86639348
- Mark type
- Stylized text
- Filed
- 22 May 2015
- Published for opposition
- 19 Apr 2016
- Abandoned
- 15 Jul 2019
- Attorney of record
- Michael A. Lisi
Goods and services
- Class 001 — Chemicals: Biochemical reagents for non-medical purposes; diagnostic preparations and reagents for scientific or research use; chemical and diagnostic preparations for clinical or medical laboratory use
- Class 005 — Pharmaceuticals: Diagnostic test kits for medical and clinical use comprised of reagents for use in identifying and measuring changes associated with cancer or precancerous conditions; medical diagnostic assay kits comprised of reagents for use in identifying and measuring changes associated with cancer or precancerous conditions; medical diagnostic kits comprised of medical diagnostic reagents and assays for use in the field of cancer detection; diagnostic reagents for medical purposes
- Class 010 — Medical apparatus: Apparatus for medical diagnostic testing in the field of cancer
- Class 042 — Scientific and technological services: Pharmaceutical research and development; consulting services in the fields of biotechnology and pharmaceutical research and development; custom design and development of chemical reagents and biochemical assays
- Class 044 — Medical, beauty and agricultural services: Consulting services in the field of health; consulting services in the field of diagnostic medical testing; medical analysis for the diagnosis of cancer and prognosis of expected progression of the disease; medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer; providing cancer screening services; providing a website featuring information in the fields of the diagnosis and treatment of cancer
Owner
- Nucleix, Ltd., Tel-Aviv, IL
- Nucleix, Ltd., Tel-Aviv, IL
Prosecution history
- 15 Jul 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Jul 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Mar 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Feb 2019 — SOU EXTENSION 5 GRANTED
- 14 Dec 2018 — SOU EXTENSION 5 FILED
- 27 Feb 2019 — NOTICE OF REVIVAL - E-MAILED
- 27 Feb 2019 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 27 Feb 2019 — PETITION TO REVIVE-GRANTED
- 27 Feb 2019 — TEAS PETITION TO REVIVE RECEIVED
- 14 Jan 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Jan 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Jun 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jun 2018 — SOU EXTENSION 4 GRANTED
- 11 Jun 2018 — SOU EXTENSION 4 FILED
- 11 Jun 2018 — SOU TEAS EXTENSION RECEIVED